I-COVID 19: Izitoko ezi-5 eziphezulu ze-Pharma zokutshala imali ngo-2020

Isevisi yokuhweba ngamakhophi. I-Algo yethu ivula futhi ivale ngokuzenzakalelayo ukuhweba.

I-L2T Algo inikeza amasiginali anenzuzo enkulu anengozi encane.

24/7 ukuhweba nge-cryptocurrency. Ngenkathi ulele, siyahweba.

Ukusethwa kwemizuzu eyi-10 okunezinzuzo ezinkulu. Imanuwali inikezwe ngokuthenga.

79% Izinga lempumelelo. Imiphumela yethu izokujabulisa.

Ukuhwebelana okungafika kuma-70 ngenyanga. Kunamapheya angaphezu kwama-5 atholakalayo.

Okubhaliselwe kwanyanga zonke kuqala ku-£58.

Okuthile kwe-L2T

ITHELELELI

IZIPHUMA

Yize ubhadane oluthathelana kakhulu iCorona (i-COVID-19) lubanga udlame emhlabeni wonke, imiphumela yalo yazwakala cishe kuyo yonke imikhakha yomhlaba. Amafemu e-Biotech asekuqalisweni kwesikhathi ngemuva kwezigcawu ukudala umuthi wokugomela i-pathogen. Manje kunabatshalizimali abaningi abafuna ukutshala imali kula mafemu.

1. IGlaxoSmithKline
Njengomunye wabadali bokugoma abakhulu kunabo bonke emhlabeni, le nkampani yaseBritish biotech ihamba phambili phakathi kwamafemu. Kuyaziwa njengephayona ekukhiqizeni umuthi wokugoma owehlayo.

Umuthi wokugomela umkhuhlane wonyaka kanye nomuthi wokugomela iHuman Papillomavirus (HPV) uphakathi kweminikelo ephezulu emhlabeni. Isebenzisana neClover Biopharmaceuticals, inkampani ye-biotech ezinze eChina.

Noma kunjalo, bayasebenzisana kumkhiqizo womuthi wokugoma wamaprotheni oncike ku-COVID-19.

2. USanofi
ISanofi Pasteur, inkampani yaseFrance eyenziwa nge-biotech, ingomunye wababambe iqhaza elikhulu empini yokulwa neCoronavirus ngaphansi kophiko lwayo lokugoma.

Isebenzisana ne-US Biomedical Advanced Research and Development Authority (BARDA) ngokubambisana.

IBARDA iyingxenye yoMnyango Wezempilo kanye Nezinsizakalo Zabantu (HHS), esebenza ngaphansi kweHhovisi likaNobhala Ongumsizi Wezokulungiselela Nokuphendula (ASPR).

Bonke babheka umuthi wokugomela we-SARS ngaphambi kokuqanjwa njengomuntu ongase abe yilunga. Oqokelwe ukuthola umuthi wokugoma uSARS wahlonzwa ngo-2017. Lokhu kunganikeza inkampani inzuzo kunabancintisana nabo ngoba uSARS ungowesigaba seCoronavirus.

3. UJohnson & Johnson
UJanssen, inkampani ephethwe ngumuthi wokugoma iJohnson & Johnson, naye ube yingxenye yempi yamanje kusukela ngoJanuwari 2020. Ukunqoba le mpi abezemithi baseMelika basebenzise izindlela ezimbili.

Ngakolunye uhlangothi, umtapo wolwazi wama-anti-virus uskena ukuthola imvelo yegciwane elisha. Futhi ngakolunye uhlangothi, isebenza ngomuthi wokugoma kusetshenziswa imishini efanayo naleyo eyayikade iyakhele ukugoma i-Ebola.

NjengeSanofi, lokhu futhi kusebenza ngokubambisana okukhulu neBARDA.

I-4 I-Sciences yaseGileyadi
Yaziwa kangcono ngemithi yayo elwa ne-Hepatitis C Virus (HCV), iGileyadi ibilokhu icwaninga ngomuthi wokugoma i-COVID-19. Isidakamizwa iRemdesivir okwamanje sinezivivinyo futhi sibeke inkampani phezulu ohlwini lwezinkampani ezenza imithi 'i-crème de la crème.

Lo mgomo ekuqaleni bekufanele welaphe igciwane le-Ebola kanti kuthiwa ubususize isiguli esisodwa seCoronavirus e-US. Umsebenzi omningi eChina usuqalile futhi inkampani kulindeleke ukuthi iqale izivivinyo zayo zasebusuku ngasekupheleni kwenyanga.

I-5 Regeneron Pharmaceuticals
Imvamisa, iRegeneron isebenza ngokubambisana neBARDA ukudala ikhambi laleli gciwane. Lokhu kusetshenziswa inqubo eye yaphumelela ekwakheni umuthi wegciwane le-Ebola.

Lokhu kufaka ukwethula amagundane afakwe kwizakhi zofuzo kumaprotheni we-coronavirus anamasosha omzimba afana nomuntu. Inhloso ukuthi amagundane enze ama-antibody kuma-protein. Ngesikhathi esifanayo, abantu abazinzile kusukela ekuguleni basebenzisa amasosha omzimba.

Bahlose ukukhetha okungcono kakhulu kulokhu, abazokusebenzisa ukwenza ingxube yokwelapha igciwane. Umkhiqizo uzobe usulungele ukuvivinywa kwabantu ekuqaleni kwehlobo, kusho inkampani.

I-Stock Market neCoronavirus
Lokhu kufanele kwaziswe ukukhathazeka kwesifo muva nje okudale ukungaqiniseki okukhulu kwemakethe yamasheya. Yize amanani amanye amafemu ewile kakhulu, amaningi akhuphukile. Amafemu ezokunakekelwa kwempilo nezemithi aphakathi kokunye.

Uma ucabanga ukuthi la mabhizinisi agxile ekwelashweni kwamagciwane okutheleleka kakhulu, kulandela ngokusobala ukuthi amasheya abo athola ithuba lokuthola inzuzo enkulu. Izimpahla zabo nazo ziyahlomula kumanani aphezulu ezicelo naphezu kokuqubuka.

Ngakho-ke akumangalisi ukuthi amasheya amaningi okwenziwa kwemithi, ikakhulukazi isitoko se-GILD, abekhuphuke kakhulu, edlula i-S & P 500 yize iqale ukwehla kwayo ngoFebhuwari.

I-COVID 19 Ukulindela Umuthi
Kungathatha isikhathi esithile, okungenani unyaka owodwa noma ngaphezulu, ngokusho kochwepheshe, ngaphambi kokuba umhlaba ekugcineni uthole umuthi wokugomela i-COVID-19 esabekayo.
Ngaphezu kwalokho, ukwethula lawo masheya ohlwini lokubuka utshalomali kuyindlela enhle yokugcina umkhondo wokuhamba kwawo njengoba ethola indawo ekukhuleni komuthi wokugoma.

Umhlahlandlela Wokutshala Imali Kumafemu E-Pharma
Kubathengi base-US, ngeStash Invest, umthengisi wamasheya ongenayo ikhomishini ethengisa amasheya ezemithi engu- $ 5, ungatshala imali ezinkampanini ezenza imithi.

Ngabe uzinze ngaphandle kwe-USA? Siphakamisa ukuthi i-Plus500 enikezela ngokusabalala okuphansi ekutshalweni kwamasheya ezemithi kanye nepulatifomu elawulwa kahle.